跳至主導覽 跳至搜尋 跳過主要內容

LANZHOU UNIVERSITY TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED's US Patent application for "GLUCAGON RECEPTOR ANTAGONIST AND USE THEREOF" is in published phase now

新聞/媒體: Press/Media

期間10 4月 2023

媒體報導

1

媒體報導

  • 標題LANZHOU UNIVERSITY TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED's US Patent application for "GLUCAGON RECEPTOR ANTAGONIST AND USE THEREOF" is in published phase now
    媒體名稱/出口Impact Financial News
    國家/地區United Kingdom
    日期10/04/23
    人員HUANXIANG LIU